MedTrace Logo

Drug Interaction Study of Simvastatin and Dabigatran

NCT03728101 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2019-03-12

No results posted yet for this study

Summary

The aim of the study is to evaluate the effect of simvastatin on the pharmacokinetics and pharmacodynamics of dabigatran in healthy male adults

Conditions

  • Healthy

Interventions

DRUG

Simvastatin, Dabigatran Etexilate

The subjects receive dabigatran etexilate with and without simvastatin administration

Sponsors & Collaborators

  • Korea University Guro Hospital

    lead OTHER

Principal Investigators

  • Hyewon Chung, MD, PhD · Clinical Instructor

Study Design

Purpose
BASIC_SCIENCE
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
19 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-11-16
Primary Completion
2018-12-15
Completion
2018-12-15

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03728101 on ClinicalTrials.gov